This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $10,037.40 contract will provide the NIH with Qiagen's sample and assay technologies to support the agency's biomedical research, public health, and healthcare programs. The contract does not have a set-aside designation. Qiagen has a history of providing a range of products and services to federal...
This is a $17,029.90 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The award does not have a set-aside designation. Qiagen provides a range of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is associated with a larger Qiagen indefinite delivery vehicle that...
This is a $80,260 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The contract is not set aside and has a period of performance from March 28, 2019 to April 14, 2021. Qiagen, a global provider of sample and assay technologies, has delivered a range of products and services to federal agencies, including DNA/RNA extraction kits, next-generation sequencing equipment, bioinformatics software, and other...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $7,820.97 award supports the provision of Qiagen's products and services, which include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, bioinformatics software, and precision medicine analysis tools. Qiagen has a long history...
This is a $16,800 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for NIDDK to acquire 1,000 QCII Translational biospecimen samples. Qiagen provides a wide range of molecular diagnostics products, services, and instrumentation to federal agencies, including the Department of Health and Human Services, Department of Defense,...
This firm fixed-price purchase order contract was awarded by the Office of the Chief Operating Officer (part of the Department of Health and Human Services) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $80,047.85 contract is for the delivery of Qiagen's sample and assay technologies, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and related bioinformatics software. Qiagen has provided these types of...
This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $11,437.12 contract is for the purchase of QIAGEN KITS & SUPPLIES, which are likely molecular biology products and services used to support NIAID's biomedical research, public health, and healthcare programs. Qiagen is an...
This is a $10,768.00 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The contract is for the QCII TRANSLATIONAL 1,000 SAMPLES requirement, with a performance period ending on September 28, 2025. Qiagen has provided a range of goods and services to federal agencies in the past, including DNA/RNA extraction kits, next-generation...